| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,947 |
17,089 |
$5.53M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,778 |
4,340 |
$1.35M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,433 |
4,385 |
$1.26M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,072 |
3,901 |
$1.16M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,123 |
3,089 |
$912K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,122 |
2,100 |
$611K |
| 90837 |
Psychotherapy, 53 minutes with patient |
657 |
476 |
$194K |
| 99381 |
|
422 |
414 |
$114K |
| 90834 |
Psychotherapy, 45 minutes with patient |
306 |
255 |
$91K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,657 |
9,413 |
$91K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
99 |
89 |
$28K |
| 96127 |
|
2,303 |
2,179 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
59 |
57 |
$17K |
| 99382 |
|
16 |
16 |
$4K |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
71 |
62 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
15 |
15 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
929 |
906 |
$2K |
| 91308 |
|
177 |
175 |
$541.30 |
| 83655 |
|
79 |
79 |
$530.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,815 |
2,770 |
$426.91 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,387 |
5,327 |
$316.88 |
| 92551 |
|
160 |
159 |
$266.91 |
| 90670 |
|
1,843 |
1,815 |
$243.39 |
| 90716 |
|
693 |
687 |
$144.72 |
| 0074A |
|
35 |
35 |
$120.00 |
| 0081A |
|
97 |
94 |
$120.00 |
| 90480 |
|
180 |
180 |
$101.27 |
| 85018 |
|
86 |
79 |
$96.65 |
| 90707 |
|
686 |
680 |
$83.87 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,192 |
3,154 |
$40.59 |
| 90633 |
|
1,665 |
1,650 |
$38.11 |
| 96381 |
|
59 |
58 |
$20.26 |
| 81003 |
|
313 |
301 |
$19.10 |
| 90651 |
|
1,166 |
1,153 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
25 |
$0.00 |
| 91307 |
|
124 |
120 |
$0.00 |
| 90677 |
|
537 |
536 |
$0.00 |
| 90723 |
|
2,231 |
2,199 |
$0.00 |
| 90686 |
|
1,725 |
1,708 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
390 |
382 |
$0.00 |
| 99174 |
|
536 |
533 |
$0.00 |
| 90696 |
|
745 |
732 |
$0.00 |
| 90656 |
|
157 |
157 |
$0.00 |
| 0173A |
|
15 |
15 |
$0.00 |
| 91305 |
|
57 |
57 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
25 |
25 |
$0.00 |
| 91315 |
|
14 |
14 |
$0.00 |
| 0154A |
|
16 |
15 |
$0.00 |
| 87807 |
|
17 |
17 |
$0.00 |
| 91317 |
|
16 |
16 |
$0.00 |
| 87428 |
|
13 |
13 |
$0.00 |
| 90381 |
|
13 |
13 |
$0.00 |
| 90660 |
|
14 |
14 |
$0.00 |
| 0051A |
|
12 |
12 |
$0.00 |
| 90734 |
|
952 |
937 |
$0.00 |
| 90473 |
|
826 |
818 |
$0.00 |
| 90681 |
|
1,370 |
1,348 |
$0.00 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
148 |
142 |
$0.00 |
| 90700 |
|
661 |
658 |
$0.00 |
| G9920 |
Screening performed and negative |
230 |
228 |
$0.00 |
| 90710 |
|
836 |
820 |
$0.00 |
| 90461 |
|
2,160 |
2,126 |
$0.00 |
| 90715 |
|
524 |
513 |
$0.00 |
| 90648 |
|
2,868 |
2,832 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
43 |
43 |
$0.00 |
| 90672 |
|
252 |
248 |
$0.00 |
| 0054A |
|
44 |
44 |
$0.00 |
| 90671 |
|
537 |
529 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
595 |
578 |
$0.00 |
| 91312 |
|
36 |
36 |
$0.00 |
| 91322 |
|
13 |
13 |
$0.00 |
| 91321 |
|
94 |
94 |
$0.00 |
| 0124A |
|
43 |
43 |
$0.00 |
| 0071A |
|
28 |
28 |
$0.00 |